Surgery with double tissue closure for jaw bone damage from medicines
Tests a jaw surgery for bone damage caused by medicines.
Key facts
- Who runs it
- Tanta University
- Where
- Egypt1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Management of Medication Related Osteonecrosis of the Jaws With Double Periosteal Flap Closure
- Status
- Enrolling by invitation
- People taking part
- 20 people, planned
- Started
- 3 Jan 2025
- Expected to end
- 26 Dec 2026
- Type of study
- Interventional
- Treatments tested
- management of medication related osteonecrosis of the jaw
- Record updated
- 19 May 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for people with medication related osteonecrosis of the jaw (MRONJ), meaning jaw bone damage caused by medicines. They will have surgery to remove the damaged bone, then the wound is closed with a double tissue flap.
- Sex
- All sexes can join.
- Disease stage
- MRONJ that needs more than conservative (non-surgical) treatment.
- Earlier treatment
- People who have had radiotherapy in the past cannot join.
Main reasons for not taking part
- Past radiotherapy
- Only conservative (non-surgical) treatment is needed
The registry criteria, word for word
Show all 3 criteriaShow less
Who can take part
- patients with MRONJ
Who cannot take part
- Patients had a history of radiotherapy
- Patients need only conservative treatment
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
20 patients with MRONJ underwent surgical debridement using piezosurgery then closure using double periosteal flap
The group in the trial
- management of medication related osteonecrosis of the jawTreatment being tested
The buccal mucoperiosteal flap was elevated to expose the area of osteonecrosis in the mandible. it was debrided using piezosurgery then closure was achieved using double periosteal flap
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Management of Medication Related Osteonecrosis of the Jaws Using Piezosurgery With Simultaneous Double Periosteal Flap Closure
- Plain-language title
- Surgery with double tissue closure for jaw bone damage from medicinesGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 15 November 2026.
- Record updated
- 19 May 2026